SEC Filings TLDR

On October 24, 2025, Alberto Horihuela, the Chief Operating Officer of fuboTV Inc., received 350,785 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of fuboTV Inc. common stock. The RSUs will vest in four equal installments on November 23, 2026, November 23, 2027, November 23,...

Janedis John, the Chief Financial Officer of fuboTV Inc., received 350,785 restricted stock units (RSUs) on October 24, 2025. Each RSU represents a contingent right to receive one share of fuboTV Inc. common stock. The RSUs will vest in four equal installments on November 24, 2026, November 24, 2027, November 24, 2028,...

David Gandler, Chief Executive Officer of fuboTV Inc., has been granted 523,560 Restricted Stock Units (RSUs) on October 24, 2025. Each RSU represents a contingent right to receive one share of fuboTV Inc. common stock. The RSUs will vest in four equal installments on November 22, 2026, November 22, 2027, November 22, ...

Jennifer Anne Smith, Executive Vice President of Zions Bancorporation, National Association, reported two transactions involving the company's common stock on October 27, 2025. The first transaction was a sale of 2,457.612 shares at a weighted average price of $53.108 per share, resulting in a post-transaction ownershi...

Michael L Hansen, a director of Waterstone Financial, Inc., sold a total of 81,413 shares of common stock on October 27, 2025. The shares were sold at a weighted average price of $15.16 per share, with transactions ranging from $15.15 to $15.35. The sales included 1,541 shares held indirectly through a trust and 79,872...

On October 24, 2025, Pauline Richards, a director of Wyndham Hotels & Resorts, Inc., acquired additional shares of common stock. The transactions included the acquisition of 455 shares at $74.76 per share, increasing her total holdings to 17,373 shares, and 337 shares at the same price, increasing her total holdings to...

On October 24, 2025, Ronald L. Nelson, a director of Wyndham Hotels & Resorts, Inc., acquired 515 shares of common stock at a price of $74.76 per share. Following this transaction, Nelson's total holdings in the company increased to 17,363 shares. The filing also details Nelson's other holdings, including 3,511 restric...

Stephen P. Holmes, a director of Wyndham Hotels & Resorts, Inc., reported a transaction involving the acquisition of 682 shares of common stock on October 24, 2025, at a price of $74.76 per share. Following this transaction, Holmes owns a total of 21,325 shares directly. Additionally, Holmes holds 3,511 restricted stoc...

On October 24, 2025, Mukul Deoras, a director of Wyndham Hotels & Resorts, Inc., acquired 540 shares of common stock at a price of $74.76 per share. Following this transaction, Deoras directly owns 22,075 shares of common stock. The acquisition was part of deferred stock units issued for quarterly retainer fees and div...

On October 24, 2025, James E. Buckman, a director of Wyndham Hotels & Resorts, Inc., acquired 1,026 shares of common stock at a price of $74.76 per share. Following this transaction, Buckman directly owned 91,498 shares of common stock. Additionally, Buckman holds 3,511 restricted stock units and 9,307 shares of common...

Bruce Churchill, a director of Wyndham Hotels & Resorts, Inc., acquired 597 shares of common stock on October 24, 2025, at a price of $74.76 per share. This transaction increased his total holdings to 27,215 shares. The shares were acquired as deferred stock units, which entitle Churchill to receive one share of common...

On October 24, 2025, Myra J. Biblowit, a director of Wyndham Hotels & Resorts, Inc., acquired additional shares of common stock. The transactions included 434 shares at $74.76 per share, increasing her holdings to 13,273 shares, and 499 shares at the same price, increasing her holdings to 91,477 shares. These acquisiti...

Andrea B Smith, a director of World Kinect Corp, received a grant of 4,259 restricted stock units (RSUs) on October 24, 2025. These RSUs were issued as part of a restricted stock unit grant and will vest on the earlier of the day prior to the next annual meeting of shareholders or the one-year anniversary of the grant ...

Jeffrey G. Lindeman, VP, Chief People, Culture & Capital at WD-40 Co., reported two transactions involving the company's common stock on October 27, 2025. In the first transaction, Lindeman disposed of 260 shares at $0 per share, leaving him with 5,194 shares. In the second transaction, he disposed of 294 shares at $0 ...

Phenix Q. Kiamilev, VP, GC & Chief Compliance Officer of WD-40 Co, reported two transactions involving the disposal of shares of Common Stock on October 27, 2025. The first transaction involved the disposal of 267 shares, reducing her holdings to 4,542 shares. The second transaction involved the disposal of 294 shares,...

Sara K. Hyzer, VP, Finance & CFO of WD-40 Co., reported two transactions involving the company's common stock on October 27, 2025. The first transaction involved the disposal of 533 shares at $0 per share, reducing her holdings to 6,190 shares. The second transaction involved the disposal of 455 shares at $0 per share,...

Steven A. Brass, President and CEO of WD-40 Company, reported two transactions involving the company's common stock on October 27, 2025. The first transaction involved the disposal of 2,380 shares, reducing his holdings to 35,371 shares. The second transaction involved the disposal of 1,972 shares, further reducing his...

Tony D Oh, Senior Vice President, Chief Accounting Officer and Controller of Voya Financial, Inc., reported several stock transactions on October 24, 2025. Oh acquired 1,018 shares of common stock at $73.54 per share and disposed of 301 shares at the same price, resulting in a post-transaction ownership of 717 shares. ...

On October 27, 2025, Gregg Williams, a director and ten percent owner of Vivani Medical, Inc., acquired 3,703,703 shares of the company's common stock in a private sale transaction at a price of $1.62 per share. This transaction increased his total holdings to 21,350,815 shares. The purchase price was based on the last...

SVF Endurance (Cayman) Ltd, along with related entities SoftBank Vision Fund (AIV M1) L.P. and SB Investment Advisers (UK) Ltd, reported the sale of shares in Vir Biotechnology, Inc. (VIR) pursuant to a Rule 10b5-1 trading plan. The transactions occurred on October 24, 2025, and October 27, 2025. On October 24, 2025, 4...

Marianna Mancini, Chief Operating Officer of Viking Therapeutics, Inc., reported two significant stock transactions. On October 27, 2025, she acquired 11,117 shares of common stock at $0 per share, increasing her total holdings to 388,652 shares. This acquisition was part of a performance restricted stock unit award gr...

On October 27, 2025, Rowland Charles A Jr, a director of Viking Therapeutics, Inc., engaged in multiple transactions involving the company's common stock. He acquired a total of 60,000 shares at prices ranging from $4.48 to $5.80 per share, increasing his holdings to 90,000 shares. Subsequently, he sold 60,000 shares a...

The filing reports two significant stock transactions by Brian Lian, the President & CEO of Viking Therapeutics, Inc. On October 27, 2025, Lian acquired 70,084 shares of common stock as part of a performance restricted stock unit award that vested upon the achievement of non-financial performance goals. This transactio...

The filing details the stock transactions of Greg Zante, the Chief Financial Officer of Viking Therapeutics, Inc. On October 27, 2025, Zante acquired 11,117 shares of common stock at $0 per share, increasing his total holdings to 179,777 shares. This acquisition was part of a performance restricted stock unit award gra...

The filing details the stock transactions of Andrew D'Amico, a director at Vicor Corp, on October 24, 2025. D'Amico engaged in multiple transactions involving the company's common stock and non-qualified stock options. He acquired and disposed of shares of common stock at various prices, with transactions ranging from ...